Effect of Myofascial Release With and Without Taping in Patient With Heel Spur: (NCT07588776) | Clinical Trial Compass
CompletedNot Applicable
Effect of Myofascial Release With and Without Taping in Patient With Heel Spur:
Pakistan38 participantsStarted 2026-04-06
Plain-language summary
The current study is a randomized controlled trial comparing the effectiveness of myofascial release therapy used alone versus myofascial release combined with clinical taping for individuals with heel spurs. The trial aims to evaluate improvements in pain, foot function, and overall disability. Interventions will be delivered twice weekly for a specified duration. The primary outcome is pain reduction, while secondary outcomes include improved foot function and reduced disability. The hypothesis is that the combination of myofascial release and taping will result in significantly greater clinical improvements compared to myofascial release alone.
Who can participate
Age range
30 Years – 40 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Age 30-40 years
* Both males and females
* Clinically or radiographically confirmed heel spur
* Pain intensity ≥ 3 on Visual Analog Scale
* Symptom duration ≥ 4 weeks
* Able to attend treatment sessions 3 times per week
* Able to provide informed consent
Exclusion Criteria:
* Previous foot or heel surgery
* Current physiotherapy treatment for heel pain
* Neurological disorders (e.g., neuropathy, radiculopathy)
* Systemic inflammatory diseases (e.g., rheumatoid arthritis, gout)
* Severe musculoskeletal deformities of the foot
* Open wounds, skin infection, or allergy to tape
* Corticosteroid injection in the last 3 months
* Pregnancy
* Any medical condition preventing safe participation
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Pain Intensity
Timeframe: Baseline and 4 weeks post-intervention.